Inayat Faisal, Hussain Amna, Yahya Sidra, Weissman Simcha, Sarfraz Nuraiz, Faisal Muhammad Salman, Riaz Iqra, Saleem Saad, Saif Muhammad Wasif
Allama Iqbal Medical College, Lahore, Pakistan.
Fatima Jinnah Medical University, Lahore, Pakistan.
Transl Gastroenterol Hepatol. 2022 Jan 25;7:10. doi: 10.21037/tgh.2020.02.17. eCollection 2022.
Dieulafoy's lesion is an abnormally large, tortuous, submucosal vessel that erodes the overlying mucosa, without primary ulceration or erosion. Although these lesions predominantly involve the stomach and upper small intestine, they are being detected with increasing frequency in the rectum. We conducted a systematic literature search of MEDLINE, Cochrane, Embase, and Scopus databases for adult rectal Dieulafoy's lesion. After careful review of the search results, a total of 101 cases were identified. The data on patient characteristics, clinical features, colonoscopy findings, diagnosis, treatment, and clinical outcomes were collected and analyzed. The mean age of presentation was 66±17 years (range, 18-94 years), with 54% of cases reported in males. Clinical presentation was dominated by acute lower gastrointestinal bleeding in the form of bright-red blood per rectum 47% and hematochezia 36%, whereas 16% of patients were admitted with symptoms related to other medical conditions. Major underlying disorders were hypertension 29%, diabetes mellitus 21%, and chronic kidney disease 16%. The average number of colonoscopies required for the diagnosis of rectal Dieulafoy's lesion was 1.5±0.7. In regard to treatment, endoscopic therapy was applied in 80%, direct surgical suturing in 12%, angiographic embolization in 4%, and endoscopic therapy followed by surgical ligation was performed in 4% of patients. The endoscopic treatment was a feasible choice for rectal disease, with a primary hemostasis rate of 88%. Although the overall mortality rate was 6%, the causes of death were unrelated to this entity. This review illustrates that patients with rectal Dieulafoy's lesion can have a favorable clinical outcome. Prompt diagnosis and appropriate management are of paramount importance to prevent serious hemodynamic complications. The best therapeutic modality remains to be determined but the data presented here support the use of mechanical endoscopic methods as safe and effective.
迪厄拉富瓦病损是一种异常粗大、迂曲的黏膜下血管,其侵蚀覆盖其上的黏膜,但无原发性溃疡或糜烂。尽管这些病损主要累及胃和上小肠,但在直肠中被检测到的频率越来越高。我们对MEDLINE、Cochrane、Embase和Scopus数据库进行了系统的文献检索,以查找成人直肠迪厄拉富瓦病损的相关文献。在仔细审查检索结果后,共确定了101例病例。收集并分析了有关患者特征、临床特征、结肠镜检查结果、诊断、治疗和临床结局的数据。出现症状的平均年龄为66±17岁(范围为18 - 94岁),54%的病例报告为男性。临床表现以急性下消化道出血为主,表现为直肠鲜红色血便占47%,便血占36%,而16%的患者因与其他疾病相关的症状入院。主要基础疾病为高血压占29%,糖尿病占21%,慢性肾脏病占16%。诊断直肠迪厄拉富瓦病损所需的结肠镜检查平均次数为1.5±0.7次。在治疗方面,80%的患者采用内镜治疗,12%采用直接手术缝合,4%采用血管造影栓塞,4%的患者采用内镜治疗后进行手术结扎。内镜治疗是直肠疾病的一种可行选择,初次止血率为88%。尽管总死亡率为6%,但死亡原因与该病损无关。本综述表明,直肠迪厄拉富瓦病损患者可获得良好的临床结局。及时诊断和适当管理对于预防严重的血流动力学并发症至关重要。最佳治疗方式仍有待确定,但此处提供的数据支持使用机械内镜方法是安全有效的。